The use of Avastin alone to treat a subgroup of recurrent Grade 3 brain tumors showed it was safe and effective at delaying tumor progression, according to a retrospective study of 22 patients conducted by a researcher at the Seattle Cancer Care Alliance.
Full article >>
Monday, April 6, 2009
Avastin effective at delaying brain tumor progression in recurrent disease
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment